TELO Telo Genomics Corp.

0.0550CAD+10.00%Mkt Cap: 4.02M $P/E: —

Telo Genomics Corp., a molecular diagnostics company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions, primarily …

Key Statistics

Company
Market Cap4.02M USD
Enterprise Value3.90M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-1.98M USD
Revenue/Share—
Last Price0.0550 CAD
Fiscal Year EndJun 2025
MR QuarterMar 2026
Employees—
CountryCA
SectorHealthcare
IndustryDiagnostics & Research
ISINCA87975M2085
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-2.45
EV/Revenue—
P/S—
P/B-5.00
EPS (TTM)-0.03
EPS (Forward)—
52W Range
0.025037% of range0.1050
52W High0.1050 CAD
52W Low0.0250 CAD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-527.93%
ROA-298.34%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.70M USD
CapEx (TTM)2.37K USD
FCF Margin—
FCF Yield-10.99%
Net Debt247.31K USD
Net Debt/EBITDA-0.16
Balance Sheet
Debt/Equity—
Current Ratio0.49
Quick Ratio0.48
Book Value/Sh-0.01 CAD
Cash/Share0.01 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 CAD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay DateNov 22, 2019
Splits
Last Split1:5
Split DateNov 22, 2019
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.100.43M
Float97.44M
Insiders2.98%
Institutions0.40%
Short Interest
Short Ratio0.0d
Short % Out.0.00%
Shares Short853
Short (prev mo.)14.30K
Technical
SMA 500.0442 (+24.4%)
SMA 2000.0496 (+10.9%)
Beta0.11
S&P 52W Chg16.45%
Avg Vol (30d)91.36K
Avg Vol (10d)107.70K
Technical Indicators
RSI (14)60.5
MACD0.0022
MACD Signal0.0003
MACD Hist.+0.0019
BB Upper0.0591 CAD
BB Middle0.0440 CAD
BB Lower0.0289 CAD
BB Width68.54%
ATR (14)0.0095 CAD
Vol Ratio (20d)1.28x